Categories: Approval

Lupin gets FDA endorsement for non specific Tamiflu for Oral Suspension

Mumbai, Febraury 22, 2018: Pharma real Lupin declared that it has gotten last endorsement for its Oseltamivir Phosphate for Oral Suspension from the Assembled States Sustenance and Medication Organization (FDA).

The Pharma Times News Bureau

Share
Published by
The Pharma Times News Bureau
Tags: FDALupinMedicationOseltamivirTamiflu for Oral Suspensionthepharmatimes.in
7 years ago

Recent Posts

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

16 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

3 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago

To Mark “World Stroke Day” Sri Ramakrishna Hospital Emphasizes the Importance of “Golden Window” and Shares Insights on the Hospital’s “Advanced Stroke Centre”

Coimbatore, October 30, 2024: Sri Ramakrishna Hospital’s Neurology experts observes “World Stroke Day” on October…

6 days ago

SpOvum® Launches ARTGPT Redefining Patient Support in Assisted Reproductive Technology (ART)

Launched for 1st time in India, ARTGPT is designed to address queries regarding A.R.T treatments Product created…

1 week ago